Cervical Total Disc Replacement Device Market Size, Share, Growth, Industry Analysis, Trends and Dynamics, By Types (Metal on a Biocompatible Material (M-o-B), Metal on Metal (M-o-M)), By Applications (Hospitals, Ambulatory Surgical Centers, Orthopedic and Trauma Centers), Regional Insights and Forecast to 2035
- Last Updated: 20-November-2026
- Base Year: 2025
- Historical Data: 2021-2024
- Region: Global
- Format: PDF
- Report ID: GGI101006
- SKU ID: 30558325
- Pages: 116
Download FREE Sample
Cervical Total Disc Replacement Device Market Size
The global Cervical Total Disc Replacement Device Market was valued at USD 2,226.2 million in 2025 and is projected to reach USD 2,623.08 million in 2026 and USD 3,090.8 million in 2027, before expanding to USD 11,483.85 million by 2035. The market is expected to register a CAGR of 17.83% during the 2026–2035 forecast period. Growth reflects increasing adoption of motion-preserving cervical procedures, improvements in artificial disc engineering, and broader clinical acceptance of cervical disc arthroplasty as an alternative to traditional spinal fusion. Advancements in implant materials, anatomical design, and surgical instrumentation are strengthening procedural confidence, while growing awareness of preserving cervical mobility is supporting demand across specialized spine-care facilities. Approximately 65% of market demand is associated with established surgical treatment pathways, while expanding access to advanced spinal interventions is creating additional opportunities.
The United States represents a strategically important market because of its established spine-surgery infrastructure, experienced neurosurgical workforce, and comparatively broad access to advanced implant technologies. Increasing preference for motion preservation and improved patient selection are encouraging surgeons to consider artificial cervical discs for appropriate degenerative conditions. Around 58% of eligible procedures are influenced by clinical considerations involving mobility preservation, adjacent-segment health, and long-term functional outcomes. Continued investment in surgical training and implant innovation is expected to reinforce adoption.
![]()
In the US Cervical Total Disc Replacement Device Market, demand is supported by specialized spine centers, favorable reimbursement pathways for selected procedures, and increasing familiarity with cervical disc arthroplasty. Nearly 62% of purchasing decisions in advanced hospitals are influenced by implant performance, surgeon experience, and clinical evidence. Manufacturers are emphasizing simplified instrumentation, anatomical compatibility, and durable implant materials to strengthen hospital adoption. Growing attention to patient recovery and preservation of cervical movement is also supporting the procedure's position within modern spinal treatment strategies.
Key Findings
- Market Size: The market is projected to increase from USD 2,623.08 million in 2026 to USD 3,090.8 million in 2027 and USD 11,483.85 million by 2035, registering a CAGR of 17.83%.
- Growth Drivers: Motion-preserving procedures influence 65% of adoption decisions, while improved implant designs support 48% of surgeon preference.
- Trends: Advanced implant materials account for 52% of product innovation priorities, while patient-specific anatomical compatibility influences 44% of purchasing considerations.
- Key Players: Medtronic, Plc., Depuy Synthes (Johnson & Johnson Inc.), Stryker Corporation, Zimmer Biomet Holdings, Inc., and Globus Medical, Inc.
- Regional Insights: North America holds 38%, Europe 27%, Asia-Pacific 26%, and Middle East & Africa 9% of the global market, collectively representing 100%.
- Challenges: Implant costs affect 42% of procurement decisions, while surgeon training requirements influence 35% of adoption barriers.
- Industry Impact: Motion preservation influences 61% of treatment preferences, while minimally invasive surgical planning supports 46% of clinical decision-making.
- Recent Developments: Implant engineering improvements influence 49% of product development priorities, while clinical evidence supports 43% of adoption strategies.
- Unique Information: Cervical artificial discs are designed to preserve movement at the treated spinal level. Their selection depends on patient anatomy, disc degeneration, facet-joint condition, bone quality, and surgeon assessment rather than implant availability alone.
The Cervical Total Disc Replacement Device Market is evolving through the convergence of implant engineering, clinical evidence, and changing preferences in spinal treatment. Device selection increasingly considers the balance between preserving movement and achieving reliable segmental stability. Approximately 54% of purchasing considerations are associated with clinical performance and implant compatibility, highlighting the importance of evidence-based product differentiation.
Market competition is increasingly shaped by implant durability, surgical usability, and the ability to accommodate variations in cervical anatomy. Manufacturers are focusing on improved instrumentation and materials to strengthen procedural consistency. Around 47% of product evaluation priorities relate to long-term functional performance, while surgeon familiarity remains an important factor in hospital-level purchasing decisions.
![]()
Cervical Total Disc Replacement Device Market Trends
The Cervical Total Disc Replacement Device Market is increasingly influenced by the shift toward motion-preserving spinal procedures. Unlike conventional fusion approaches that eliminate movement at the treated segment, artificial cervical discs are designed to maintain controlled mobility while addressing symptomatic disc degeneration. This clinical distinction is encouraging greater attention to patient selection, implant geometry, and long-term functional outcomes. Approximately 58% of treatment considerations in suitable candidates are associated with preserving cervical movement and maintaining functional spinal mechanics. Surgeons are also evaluating disc height restoration, range of motion, implant positioning, and compatibility with individual anatomical characteristics. These factors are encouraging manufacturers to refine device profiles and instrumentation to support more predictable implantation. Growing familiarity with cervical arthroplasty is also strengthening its position in specialized spine-care facilities, although the procedure remains dependent on clinical eligibility and the condition of surrounding spinal structures.
Material innovation and improvements in implant construction represent another important market trend. Manufacturers are refining metal-bearing surfaces, polymer cores, endplate configurations, and fixation mechanisms to improve durability and reduce complications associated with implant migration or wear. Approximately 51% of product development priorities are directed toward improving material performance, implant stability, and long-term mechanical reliability. Greater attention is also being given to anatomical sizing options and instrumentation that can simplify surgical placement. Hospitals increasingly evaluate devices through a combination of clinical evidence, procedural efficiency, surgeon familiarity, and total treatment considerations. Digital preoperative planning and improved imaging assessment are supporting more accurate patient evaluation and implant positioning. At the same time, long-term clinical follow-up remains essential because differences in patient anatomy, degeneration severity, and implant design can influence outcomes. These developments are encouraging a more evidence-oriented and technologically differentiated competitive environment.
Cervical Total Disc Replacement Device Market Dynamics
Expansion of Motion-Preserving Spine Treatment
Increasing clinical interest in preserving cervical mobility is creating opportunities for artificial disc manufacturers. Approximately 55% of eligible treatment evaluations emphasize functional movement preservation, encouraging the development of devices with improved anatomical conformity, controlled articulation, and dependable fixation. Emerging healthcare markets also offer opportunities as specialist spine centers expand their surgical capabilities. Companies that combine clinical evidence, surgeon education, and comprehensive instrumentation can strengthen adoption among hospitals and ambulatory surgical facilities.
Increasing Preference for Cervical Motion Preservation
The preference for maintaining movement at the treated spinal segment is a major factor supporting market growth. Cervical total disc replacement offers an alternative to fusion for appropriately selected patients with symptomatic cervical disc disease. Around 60% of clinical adoption considerations are influenced by mobility preservation, functional expectations, and patient suitability. Improvements in implant geometry, fixation surfaces, and surgical instrumentation are also strengthening surgeon confidence. In addition, the growing availability of specialist spine facilities is supporting procedural access. Manufacturers are responding through product refinement, clinical education, and evidence generation, making device performance and surgical familiarity important competitive differentiators.
| Market Driver | Impact Rank | Contribution | 2026-2028 | 2029-2031 | 2032-2035 |
|---|---|---|---|---|---|
| Increasing preference for motion-preserving cervical procedures | High | 5.40% | High | High | Medium |
| Rising prevalence of cervical degenerative disc disorders | High | 4.50% | High | High | High |
| Advancements in artificial disc materials and implant engineering | Medium | 3.80% | Medium | High | High |
| Expansion of specialist spine surgery infrastructure | Medium | 3.20% | Medium | Medium | High |
| Increasing surgeon awareness and clinical experience | Low | 2.50% | Medium | Medium | Low |
| Broader patient access and product portfolio availability | Lowest | 1.93% | Low | Medium | Medium |
| Total Driver Contribution | 21.33% |
Restraint
"High Treatment Costs and Restricted Patient Eligibility"
The Cervical Total Disc Replacement Device Market faces restraints associated with implant affordability, reimbursement differences, and the clinical requirements governing patient eligibility. Artificial disc procedures require specialized implants, trained surgical teams, and appropriate operating-room infrastructure, which can increase treatment costs compared with some conventional alternatives. Approximately 39% of procurement assessments are influenced by device affordability and institutional budget considerations. Clinical restrictions also limit the addressable patient population because severe facet-joint degeneration, osteoporosis, spinal instability, and advanced deformity may make disc replacement unsuitable. Around 34% of patient-selection challenges are associated with anatomical or clinical factors requiring alternative treatment approaches. Furthermore, hospitals must evaluate long-term device performance, potential revision requirements, and the strength of supporting clinical evidence. These factors can lengthen purchasing decisions and create differences in adoption across healthcare systems. Manufacturers must therefore demonstrate clinical value, provide transparent procedural guidance, and support appropriate patient selection to reduce adoption barriers.
| Market Restraint | Impact Rank | Negative CAGR Impact | 2026-2028 | 2029-2031 | 2032-2035 |
|---|---|---|---|---|---|
| High implant and procedural treatment costs | High | -1.20% | High | High | Medium |
| Restricted eligibility due to anatomical and clinical conditions | Medium | -1.00% | High | Medium | Medium |
| Uneven reimbursement and limited specialist infrastructure | Low | -0.80% | Medium | Medium | Low |
| Surgeon training requirements and long-term evidence gaps | Lowest | -0.50% | Medium | Low | Low |
| Total Restraint Impact | -3.50% |
Challenge
"Clinical Selection, Long-Term Performance, and Procedural Complexity"
One of the principal challenges facing the market is ensuring that cervical total disc replacement is offered to patients who are clinically appropriate for motion-preserving surgery. Not all individuals with cervical degenerative disc disease are suitable candidates, particularly when extensive facet-joint damage, poor bone quality, instability, or advanced degeneration is present. Approximately 36% of treatment-selection difficulties are associated with anatomical and clinical eligibility considerations. Another challenge involves demonstrating consistent long-term implant performance across different patient groups and device designs. Around 32% of hospital evaluation priorities are linked to durability, complication management, and the availability of extended clinical follow-up. Surgical expertise also influences outcomes, requiring manufacturers and healthcare providers to invest in training and procedural standardization. Variations in reimbursement policies and institutional purchasing criteria can further complicate market expansion. Addressing these challenges requires stronger clinical education, careful patient assessment, continuous post-market monitoring, and transparent communication of device-specific indications and limitations.
Segmentation Analysis
The Cervical Total Disc Replacement Device Market is segmented by implant construction and healthcare application. Product selection depends on bearing material, articulation design, fixation characteristics, anatomical compatibility, and the clinical requirements of the patient. Metal-on-biocompatible-material and metal-on-metal systems represent distinct engineering approaches, with differences in bearing interfaces and performance considerations. Hospitals, ambulatory surgical centers, and orthopedic and trauma centers contribute to demand through their respective surgical capabilities and patient-care models. Approximately 57% of purchasing considerations are influenced by clinical performance and implant compatibility, while procedural infrastructure and surgeon familiarity account for an important share of institutional decisions. These segments reflect differences in technology preferences, treatment settings, and access to specialist spinal care.
By Type
Metal on a Biocompatible Material (M-o-B)
Metal on a biocompatible material implants combine metallic endplates with a polymeric or other biocompatible bearing component. This construction is intended to provide controlled articulation while maintaining the structural support required for cervical movement. Material selection, bearing wear, implant stability, and endplate integration are important factors in product evaluation. Approximately 56% of type-related purchasing considerations are associated with material compatibility, durability, and mechanical performance. These systems appeal to healthcare providers seeking established bearing configurations and a balance between mobility and implant stability. Manufacturers continue to refine surface treatments, component geometry, and fixation mechanisms to improve implantation consistency. Their adoption also depends on clinical evidence, device-specific indications, and surgeon familiarity with the relevant instrumentation.
Metal on Metal (M-o-M)
Metal-on-metal cervical artificial discs use opposing metallic bearing surfaces to facilitate articulation and preserve movement at the treated spinal level. Their design emphasizes mechanical strength, controlled motion, and structural durability. Product assessment considers wear characteristics, surface finish, fixation, and the potential biological implications of metallic debris. Approximately 44% of type-related evaluation priorities are associated with articulation performance and long-term material behavior. These devices can appeal to surgeons familiar with metallic bearing systems, although their use requires careful consideration of device-specific clinical evidence and patient suitability. Differences in implant geometry and motion characteristics influence the choice of product. Continued engineering improvements and long-term monitoring remain important for maintaining confidence in this segment.
By Application
Hospitals
Hospitals represent a major application segment because they generally provide the multidisciplinary infrastructure required for complex cervical spine procedures. Their capabilities include specialist neurosurgery and orthopedic teams, advanced imaging, anesthesia services, postoperative monitoring, and access to revision-care resources. Approximately 61% of institutional purchasing considerations are influenced by clinical evidence, implant reliability, and surgeon preference. Larger hospitals may also support the introduction of newer artificial disc systems through structured training and evaluation programs. Their purchasing decisions typically involve clinical departments, procurement teams, and hospital administrators. The availability of comprehensive perioperative services makes hospitals important centers for treating patients with cervical degenerative disorders who meet the indications for disc replacement.
Ambulatory Surgical Centers
Ambulatory surgical centers offer opportunities for selected cervical disc replacement procedures where patient condition, surgical complexity, clinical protocols, and regulatory requirements permit outpatient treatment. Their operating models emphasize efficient scheduling, standardized perioperative processes, and coordinated recovery pathways. Approximately 42% of purchasing considerations in this segment relate to procedural efficiency, equipment requirements, and predictable patient management. However, the adoption of cervical artificial discs depends on appropriate patient selection and the availability of qualified spine surgeons and emergency transfer arrangements. Not every cervical disc replacement candidate is suitable for an ambulatory setting. Facilities must assess clinical risk, postoperative monitoring needs, reimbursement arrangements, and implant availability before expanding their procedural offerings.
Orthopedic and Trauma Centers
Orthopedic and trauma centers contribute to market demand through their specialization in musculoskeletal disorders, spinal conditions, and surgical management of cervical pathologies. These facilities often have established relationships with implant manufacturers and experienced orthopedic spine specialists. Approximately 48% of purchasing priorities are associated with implant functionality, surgeon familiarity, and suitability for individual cervical anatomy. Their role is particularly relevant in multidisciplinary treatment planning, where imaging findings, neurological symptoms, bone quality, and spinal stability must be evaluated together. Although cervical total disc replacement is not appropriate for every traumatic or degenerative condition, specialist centers can identify eligible patients and provide access to advanced motion-preserving procedures. Their clinical expertise supports informed device selection and postoperative assessment.
![]()
Cervical Total Disc Replacement Device Market Regional Outlook
Regional demand reflects differences in healthcare expenditure, access to specialist spine surgery, reimbursement structures, clinical awareness, and the availability of advanced implant technologies. North America is estimated to account for 38% of the global market, supported by established artificial disc adoption and specialist surgical infrastructure. Europe represents 27%, reflecting its advanced hospital networks and growing interest in motion-preserving procedures. Asia-Pacific contributes 26%, with demand supported by expanding healthcare investment and a large population requiring treatment for spinal disorders. Middle East & Africa accounts for the remaining 9%, where adoption is concentrated in better-equipped healthcare systems and specialist facilities. Together, these regional shares represent 100% of the global market. Regional growth will depend on clinical training, patient access, device affordability, and the availability of appropriate surgical services.
North America
North America accounts for an estimated 38% of the Cervical Total Disc Replacement Device Market, making it the leading regional segment. The United States is the principal contributor because of its established spine-surgery infrastructure, broad availability of artificial disc technologies, and experienced neurosurgical and orthopedic specialists. Approximately 64% of regional purchasing considerations are influenced by clinical evidence, surgeon familiarity, and implant performance. The presence of established manufacturers and structured clinical evaluation practices supports product adoption. Canada also contributes through specialist hospital networks and access to advanced spinal procedures. However, reimbursement differences, treatment affordability, and patient eligibility continue to influence utilization. Continued surgeon education and improvements in implant design are expected to reinforce the region's competitive position.
Europe
Europe represents approximately 27% of the global market, supported by established orthopedic treatment infrastructure, specialist spine centers, and demand for advanced surgical management of cervical degenerative conditions. Germany, France, the United Kingdom, and other developed healthcare markets contribute through specialist hospitals and experienced surgical teams. Nearly 53% of regional device evaluation priorities relate to implant reliability, clinical outcomes, and compatibility with established surgical protocols. Adoption varies across countries because reimbursement policies, procurement processes, and healthcare budgets differ. Clinical training and evidence-based treatment selection remain important to broader utilization. Manufacturers that provide regionally appropriate technical support, consistent product availability, and education for spine specialists can strengthen their position in this market.
Asia-Pacific
Asia-Pacific holds an estimated 26% market share, supported by expanding hospital infrastructure, growing specialist surgical capacity, and increasing attention to advanced spinal treatment. China, Japan, India, South Korea, and Australia represent important markets with varying levels of artificial disc adoption. Approximately 49% of regional purchasing priorities are influenced by implant affordability, clinical outcomes, and the availability of trained surgeons. Healthcare investment and improvements in diagnostic imaging are helping specialist centers identify patients who may benefit from cervical arthroplasty. However, differences in reimbursement coverage and access to advanced implants continue to shape regional demand. Manufacturers can strengthen their presence through surgeon training, localized distribution, and products suited to diverse anatomical and institutional requirements.
Middle East & Africa
Middle East & Africa accounts for approximately 9% of the global market. Demand is concentrated in countries with comparatively developed private healthcare networks, advanced hospitals, and specialist orthopedic and neurosurgical services. The United Arab Emirates, Saudi Arabia, and selected South African facilities contribute to access to advanced cervical procedures. Around 41% of regional adoption considerations are associated with specialist availability, implant procurement, and treatment affordability. Limited access to trained surgeons and uneven reimbursement coverage can restrict wider utilization, particularly in less developed healthcare systems. Investments in medical infrastructure and international clinical training partnerships are creating opportunities for gradual expansion. Manufacturers that strengthen distribution networks and provide technical education can improve access while supporting appropriate patient selection.
List of Key Cervical Total Disc Replacement Device Market Companies Profiled
- Medtronic, Plc.
- Depuy Synthes (Johnson & Johnson Inc.)
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
- Globus Medical, Inc.
- NuVasive, Inc.
- Orthofix Medical Inc.
- LDR Holding Corporation
- Centinel Spine, Inc.
- FH Orthopaedics S. A. S.
Top Companies with Highest Market Share
- Medtronic, Plc.: Estimated to hold approximately 18% of the market, supported by its established cervical implant portfolio, broad hospital relationships, and experience in spinal technologies.
- Centinel Spine, Inc.: Estimated to account for approximately 14% of the market, supported by its prodisc cervical platform and differentiated artificial disc portfolio.
Investment Analysis and Opportunities
Investment activity in the Cervical Total Disc Replacement Device Market is increasingly directed toward advanced biomaterials, implant engineering, clinical research, and expansion of specialized spine-care capabilities. Approximately 51% of investment priorities are associated with product innovation, including improved bearing surfaces, anatomical configurations, and fixation technologies. Another 29% is directed toward clinical validation, surgeon training, and postoperative performance monitoring. Companies are also exploring opportunities in emerging healthcare markets where investments in orthopedic infrastructure and neurological treatment facilities are improving access to advanced spinal procedures. Strategic partnerships with hospitals, specialist surgeons, and distributors can strengthen market penetration. Investment opportunities are particularly attractive in differentiated implant portfolios that accommodate varying cervical anatomies and surgical requirements. Manufacturers that demonstrate clinical reliability, procedural efficiency, and consistent technical support are likely to strengthen their competitive positions.
New Products Development
New product development is centered on improving implant biomechanics, material compatibility, surgical precision, and long-term mechanical reliability. Manufacturers are exploring combinations of metallic endplates, polymeric components, ceramic bearing surfaces, and advanced coatings to address different clinical requirements. Approximately 54% of development priorities are associated with material engineering and implant durability, while 31% emphasize anatomical adaptability and surgical instrumentation. Product differentiation is increasingly based on articulation characteristics, fixation mechanisms, available implant sizes, and compatibility with individual cervical structures. Multiple-device portfolios also allow surgeons to select implants according to patient anatomy and procedural requirements. Research into improved imaging assessment and standardized surgical techniques is supporting more consistent device placement. Clinical validation remains essential because implant performance must be evaluated through pain relief, functional improvement, range of motion, complications, and revision outcomes.
Five Recent Developments
- February 2024 – NGMedical GmbH expands MOVE-C commercial availability: NGMedical announced the launch of sales and the first surgical procedure using its MOVE-C artificial cervical disc in the United Arab Emirates. The development represented an important step in international commercialization and expanded access to an additional cervical motion-preserving implant option.
- October 2024 – Centinel Spine introduces prodisc C Nova in the United States: Centinel Spine announced the first US implantation of prodisc C Nova, expanding its cervical total disc replacement portfolio to four devices in clinical use.
- September 2024 – Centinel Spine reports increased prodisc C Vivo and prodisc C SK utilization: The company announced that its cervical TDR system had exceeded 7,500 US procedures since its commercial introduction. It also reported that nearly 800 surgeons had used the system, with approximately 75% of participating surgeons identified as repeat users.
- February 2025 – Centinel Spine reaches 10,000 US cervical TDR procedures: Centinel Spine announced completion of its 10,000th US procedure using the Match-the-Disc prodisc cervical system. More than 900 surgeons had used the platform, while the company reported a 46% increase in full-year 2024 US prodisc cervical TDR revenue compared with the previous year.
- October 2025 – Centinel Spine secures expanded two-level indications: Centinel Spine received FDA premarket approval for two-level indications for its prodisc C Vivo and prodisc C SK cervical total disc replacement devices. The expanded indications enabled their use in appropriately selected patients requiring reconstruction at two contiguous cervical levels.
Report Coverage
The Cervical Total Disc Replacement Device Market report provides a structured assessment of the global industry, covering product technologies, clinical applications, competitive positioning, regional demand, and emerging commercial opportunities. The study evaluates two principal implant categories: Metal on a Biocompatible Material (M-o-B) and Metal on Metal (M-o-M). It also examines demand across hospitals, ambulatory surgical centers, and orthopedic and trauma centers, highlighting differences in surgical infrastructure, procurement priorities, and patient-care requirements.
The regional assessment covers North America, Europe, Asia-Pacific, and Middle East & Africa, representing of the global market respectively. The analysis considers differences in healthcare investment, specialist availability, reimbursement arrangements, clinical awareness, and access to artificial cervical disc technologies. Competitive coverage includes Medtronic, Depuy Synthes, Stryker Corporation, Zimmer Biomet, Globus Medical, NuVasive, Orthofix Medical, LDR Holding, Centinel Spine, and FH Orthopaedics. The report also evaluates product innovation, implant materials, surgical instrumentation, clinical evidence, and manufacturer strategies. Additional coverage examines growth drivers, investment opportunities, affordability constraints, patient eligibility, and long-term device performance. These factors provide an integrated understanding of the industry's technological direction, adoption environment, and competitive development.
Cervical Total Disc Replacement Device Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 2623.08 Million in 2026 |
|
|
Market Size Value By |
USD 11483.85 Million by 2035 |
|
|
Growth Rate |
CAGR of 17.83% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Download FREE Sample
Frequently Asked Questions
-
What value is the Cervical Total Disc Replacement Device Market expected to touch by 2035?
The global Cervical Total Disc Replacement Device Market is expected to reach USD 11483.85 Million by 2035.
-
What CAGR is the Cervical Total Disc Replacement Device Market expected to exhibit by 2035?
The Cervical Total Disc Replacement Device Market is expected to exhibit a CAGR of 17.83% by 2035.
-
Who are the top players in the Cervical Total Disc Replacement Device Market?
Medtronic, Plc., Depuy Synthes (Johnson & Johnson Inc.), Stryker Corporation, Zimmer Biomet Holdings, Inc., Globus Medical, Inc., NuVasive, Inc., Orthofix Medical Inc., LDR Holding Corporation, Centinel Spine, Inc., FH Orthopaedics S. A. S.
-
What was the value of the Cervical Total Disc Replacement Device Market in 2025?
In 2025, the Cervical Total Disc Replacement Device Market value stood at USD 2226.2 Million.
About the Author(s):
This report was authored by the Healthcare Research Team at Global Growth Insights. The team specializes in pharmaceuticals, biotechnology, medical devices, diagnostics, digital health, healthcare services, and life sciences. Their expertise includes market sizing, regulatory analysis, competitive benchmarking, and healthcare trend forecasting to support strategic investment and business growth.
Our Clients
Download FREE Sample